AU2010213362B2 - Skin treatment - Google Patents

Skin treatment Download PDF

Info

Publication number
AU2010213362B2
AU2010213362B2 AU2010213362A AU2010213362A AU2010213362B2 AU 2010213362 B2 AU2010213362 B2 AU 2010213362B2 AU 2010213362 A AU2010213362 A AU 2010213362A AU 2010213362 A AU2010213362 A AU 2010213362A AU 2010213362 B2 AU2010213362 B2 AU 2010213362B2
Authority
AU
Australia
Prior art keywords
euphorbia
ingenol
skin
optionally substituted
pep005
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010213362A
Other languages
English (en)
Other versions
AU2010213362A1 (en
Inventor
James Harrison Aylward
Ryan Moseley
Steven Martin Ogbourne
David Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Laboratories Ltd
Original Assignee
Leo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Laboratories Ltd filed Critical Leo Laboratories Ltd
Publication of AU2010213362A1 publication Critical patent/AU2010213362A1/en
Assigned to LEO LABORATORIES LIMITED reassignment LEO LABORATORIES LIMITED Request for Assignment Assignors: PEPLIN RESEARCH PTY LTD
Application granted granted Critical
Publication of AU2010213362B2 publication Critical patent/AU2010213362B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AU2010213362A 2009-02-13 2010-02-12 Skin treatment Ceased AU2010213362B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15259909P 2009-02-13 2009-02-13
US61/152,599 2009-02-13
PCT/AU2010/000152 WO2010091472A1 (en) 2009-02-13 2010-02-12 Skin treatment

Publications (2)

Publication Number Publication Date
AU2010213362A1 AU2010213362A1 (en) 2011-08-04
AU2010213362B2 true AU2010213362B2 (en) 2015-07-02

Family

ID=42561329

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010213362A Ceased AU2010213362B2 (en) 2009-02-13 2010-02-12 Skin treatment

Country Status (14)

Country Link
US (1) US10143638B2 (https=)
EP (1) EP2395993B1 (https=)
JP (1) JP5638008B2 (https=)
CN (1) CN102316866A (https=)
AU (1) AU2010213362B2 (https=)
CA (1) CA2752389C (https=)
DK (1) DK2395993T3 (https=)
ES (1) ES2633755T3 (https=)
IL (1) IL214133A (https=)
NZ (1) NZ594184A (https=)
PL (1) PL2395993T3 (https=)
PT (1) PT2395993T (https=)
RU (1) RU2491050C2 (https=)
WO (1) WO2010091472A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9402823B2 (en) 2010-12-17 2016-08-02 Leo Laboratories Limited Ingenols for treating seborrheic keratosis
CN103402969A (zh) * 2010-12-22 2013-11-20 利奥实验室有限公司 3-酰基-巨大戟二萜醇ii
JP2014507396A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド イノゲノール−３−アシラートｉ
WO2012176015A1 (en) 2011-06-24 2012-12-27 Leo Pharma A/S Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
US20140350101A1 (en) * 2011-12-12 2014-11-27 Leo Laboratories Limited Gel compositions
EP2790670A1 (en) * 2011-12-12 2014-10-22 Leo Laboratories Limited Gel compositions
US20150366789A1 (en) * 2013-03-13 2015-12-24 Avon Place, Inc. Glochidium wallichianum extracts and methods of use
US9526714B2 (en) 2014-03-24 2016-12-27 Leo Laboratories Limited Method for treating skin lesions with ingenol mebutate
AU2014100280B4 (en) * 2014-03-24 2015-01-15 Leo Pharma A/S A method of treating skin lesions
BR112018074202B1 (pt) * 2016-05-24 2022-08-02 Natura Cosméticos S.A Composição cosmética antissinais, kit de composições e método para tratamento cosmético da pele
JP7557192B2 (ja) 2020-08-19 2024-09-27 日本メナード化粧品株式会社 皮膚外用剤及び内用剤

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08176004A (ja) * 1994-12-21 1996-07-09 Lion Corp 生体老化防止剤及び皮膚用組成物
US20010051644A1 (en) * 1997-08-19 2001-12-13 Aylward James Harrison Methods of stimulating the immune system
JP2002179581A (ja) * 2000-12-15 2002-06-26 Yakult Honsha Co Ltd 皮膚老化防止剤
JP2003212781A (ja) * 2002-01-22 2003-07-30 Maruzen Pharmaceut Co Ltd ヒアルロン酸産生促進剤並びに皮膚化粧料及び美容用飲食品
WO2007059584A1 (en) * 2005-11-25 2007-05-31 Peplin Research Pty Ltd Methods for wound healing
WO2008131491A1 (en) * 2007-04-30 2008-11-06 Peplin Research Pty Ltd Treatment of virally induced lesions
US20080279885A1 (en) * 2005-10-27 2008-11-13 Pele Nova Biotechnologia S.A. Topical Formulation Containing Latex of Fraction Thereof, and Cosmetic Treatment Method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0987136A (ja) * 1995-07-13 1997-03-31 Shiseido Co Ltd 皮膚外用剤
AU750624B2 (en) * 1997-08-19 2002-07-25 Leo Laboratories Limited Anti-cancer compounds-I
KR20010057776A (ko) * 1999-12-23 2001-07-05 성재갑 피부미백제
RU2229293C1 (ru) * 2003-04-24 2004-05-27 Хазанов Вениамин Абрамович Лечебно-профилактическое средство для использования в геронтологической практике
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
JP2007084448A (ja) * 2005-09-20 2007-04-05 Shiseido Co Ltd ヒアルロン酸産生促進剤および皮膚外用剤
EP2558435B1 (en) * 2010-04-16 2017-06-07 Leo Pharma A/S Orthorhombic crystalline ingenol mebutate

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08176004A (ja) * 1994-12-21 1996-07-09 Lion Corp 生体老化防止剤及び皮膚用組成物
US20010051644A1 (en) * 1997-08-19 2001-12-13 Aylward James Harrison Methods of stimulating the immune system
JP2002179581A (ja) * 2000-12-15 2002-06-26 Yakult Honsha Co Ltd 皮膚老化防止剤
JP2003212781A (ja) * 2002-01-22 2003-07-30 Maruzen Pharmaceut Co Ltd ヒアルロン酸産生促進剤並びに皮膚化粧料及び美容用飲食品
US20080279885A1 (en) * 2005-10-27 2008-11-13 Pele Nova Biotechnologia S.A. Topical Formulation Containing Latex of Fraction Thereof, and Cosmetic Treatment Method
WO2007059584A1 (en) * 2005-11-25 2007-05-31 Peplin Research Pty Ltd Methods for wound healing
WO2008131491A1 (en) * 2007-04-30 2008-11-06 Peplin Research Pty Ltd Treatment of virally induced lesions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SILLER, G. et al. Australasian Journal of Dermatology, 2009, vol 50, page 16-22. *

Also Published As

Publication number Publication date
JP2012517450A (ja) 2012-08-02
RU2011137530A (ru) 2013-03-20
JP5638008B2 (ja) 2014-12-10
EP2395993B1 (en) 2017-06-21
AU2010213362A1 (en) 2011-08-04
PT2395993T (pt) 2017-07-18
NZ594184A (en) 2014-01-31
CN102316866A (zh) 2012-01-11
PL2395993T3 (pl) 2017-10-31
CA2752389C (en) 2017-01-03
US10143638B2 (en) 2018-12-04
CA2752389A1 (en) 2010-08-19
US20120041064A1 (en) 2012-02-16
WO2010091472A1 (en) 2010-08-19
EP2395993A4 (en) 2014-09-03
IL214133A0 (en) 2011-08-31
ES2633755T3 (es) 2017-09-25
DK2395993T3 (en) 2017-08-07
IL214133A (en) 2015-03-31
RU2491050C2 (ru) 2013-08-27
EP2395993A1 (en) 2011-12-21

Similar Documents

Publication Publication Date Title
AU2010213362B2 (en) Skin treatment
ES2242237T3 (es) Composiciones de ascorbilo estabilizadas.
CA2685473C (en) Treatment of virally induced lesions
CN101677925B (zh) 包含α-红没药醇作为活性成分的改善皮肤状况的组合物
EP3329913B1 (en) Composition for inhibiting formation of snare complex, containing myricetin derivatives
KR101436199B1 (ko) 호데닌을 포함하는 피부 상태 개선용 조성물
JP2007515462A (ja) 生体適合性のガレン基剤の無害製剤方法
CN111803422A (zh) 一种控油组合物及其应用
DE10155200A1 (de) Verwendung von Cholesterin, cholesterinhaltigen Substanzen oder von den Cholesteringehalt erhöhenden Substanzen in kosmetischen und dermatologischen Zubereitungen zum Zwecke der UV-Protektion
WO2017217695A1 (ko) 알파-망고스틴, 베타-망고스틴, 감마-망고스틴 또는 가르탄닌 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 조성물
KR20140012456A (ko) 아케비아 사포닌-디를 포함하는 피부 상태 개선용 조성물
JP2005179367A (ja) 毛髪の喪失を阻止する皮膚科学的又は化粧品組成物の製造のためのエクディステロイドの使用
AU2009256524B2 (en) Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
BRPI0615427A2 (pt) composição de cuidado com a pele, composição cosmética para a pele e uso das mesmas
Xu et al. Retinol-loaded deep eutectic solvent emulsion: Improved stability and therapeutic efficiency
WO1999017715A1 (en) Extracellular matrix production promoter
JP2002516836A (ja) 皮膚の繊維芽細胞の代謝の刺激剤としてのジアセチル化ラクトンを含むソホロリピドの使用法
Yadav et al. Formulation preparation and evaluation of Apigenin ointment for anti-inflammatory and wound healing activities
JPH05229956A (ja) 酸化防止剤
KR20160016814A (ko) 화장용 레틴알데히드 및 글리실글리신 올레아미드를 조합한 화장 또는 피부과 조성물 및 이의 화장 또는 피부과 용도
JP2004168705A (ja) 肌改善用の皮膚外用剤
ES2958970T3 (es) Composiciones para uñas con propiedades antifúngicas
JP2007077101A (ja) 皮膚外用剤
KR101434446B1 (ko) 참그물바탕말을 이용한 피부 외용제 조성물
WO2005105019A1 (ja) シワ改善剤及び皮膚化粧料

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: LEO LABORATORIES LIMITED

Free format text: FORMER APPLICANT(S): PEPLIN RESEARCH PTY LTD

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired